Vaxxinity Collaborates With University Of Florida For Translational Research in Neurodegenerative Disease; State Grant Funds Research

Vaxxinity, Inc. 0.00%



Researchers at UF will conduct a series of preclinical studies to explore the effects of Vaxxinity's candidates for neurodegenerative disease on relevant biological targets, such as beta-amyloid, tau, and alpha-synuclein, in various in vitro and in vivo studies, including models of disease and antibody-target binding assays. This project will complement preclinical work conducted at Vaxxinity, which has already shown immunogenicity, target engagement, and efficacy in animal models of multiple neurodegenerative diseases including Alzheimer's and Parkinson's.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via